Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3282141 | Clinical Gastroenterology and Hepatology | 2013 | 21 Pages |
Abstract
In a systematic review, the observational evidence for the efficacy of gastroprotective agents in preventing NSAID-associated gastrointestinal events was in agreement with results of randomized controlled trials. However, because of heterogeneity of included studies, it is not clear what the effect would be if more patients were treated, or at what age gastroprotection should be recommended. We offer suggestions to facilitate comparison with other work and address the questions of risk and benefit in relation to age.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Stephanie Medlock, Saeid Eslami, Marjan Askari, Zhila Taherzadeh, Dedan Opondo, Sophia E. de Rooij, Ameen Abu-Hanna,